Position history for Mediolanum International Funds Ltd's holdings in REGENERON PHARMACEUTICALS
Mediolanum International Funds Ltd holds 71,209 shares of REGN (REGENERON PHARMACEUTICALS), worth $53.4M as of 2026-Q1. The position was increased (+56.4% shares). REGN represents 0.6% of Mediolanum International Funds Ltd's portfolio.
Current Value
$53.4M
Current Shares
71,209
Total Value Change
+$38.9M
Total Shares Change
+56,467
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 71,209 |
+56.4% |
| $53.4M |
| 0.6% |
| $766.66 |
59 |
| 2025-Q4 | Increased | 45,535 | +3528.3% | $35.2M | 0.4% | $773.94 | 56 |
| 2025-Q3 | Decreased | 1,255 | -65.0% | $703,741 | 0.0% | $560.05 | 0 |
| 2025-Q2 | Decreased | 3,591 | -89.2% | $1.9M | 0.0% | $519.56 | 0 |
| 2025-Q1 | Increased | 33,220 | +646.7% | $21.2M | 0.3% | $634.66 | 55 |
| 2024-Q4 | Increased | 4,449 | +5.3% | $3.1M | 0.0% | $698.71 | 28 |
| 2024-Q3 | Decreased | 4,225 | -71.3% | $4.4M | 0.1% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 14,742 | +14.6% | $14.5M | 0.2% | $1,045.23 | 38 |